AstraZeneca/Merck"s PARP Inhibitor In Late-Stage Breast Cancer Study To Enter Early Analysis
read more.....»»
Why Immunomedics Stock More Than Doubled
Immunomedics shares soared on Monday after the announcements that a late-stage breast cancer study was halted early and a new chief executive officer was named......»»
Knight says Health Canada approves NERLYNX for early-stage breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
How Artificial Intelligence could help with early detection of breast cancer
New research says a model developed by MIT can predict breast-cancer risk from a mammogram up to 5 years in advance......»»
How AI could help with early detection of breast cancer
New research says a model developed by MIT can predict breast-cancer risk from a mammogram up to 5 years in advance......»»
Myriad announces findings from EndoPredict study in early stage breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Many breast cancer patients can skip chemo, big study finds
Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk......»»
A study of more than 10,000 breast cancer patients found that some can skip chemotherapy without hurting their chances of beating the disease
Thomson Reuters A study found that around 70,000 early-stage breast cancer patients a year could safely skip chemotherapy without hurting their chances of beating the disease. The study used a genetic te.....»»
Many Breast Cancer Patients Don"t Get Recommended Follow-Up, Study Suggests
Women who have been treated for early-stage breast cancer should get periodic mammograms to monitor for recurrence, but the likelihood they will varies across U.S. metropolitan areas, a new study finds......»»
Cancer Research Highlight: Roche Prepares Another Assault On Early Breast Cancer
Cancer Research Highlight: Roche Prepares Another Assault On Early Breast Cancer.....»»
Myriad EndoPredict can guide chemotherapy decision in early-stage breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca to present update on ph3 trial of LYNPARZA in early breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Susan G. Komen consolidating to focus on breast cancer research
The nonprofit also will double down on direct patient support......»»
Susan G. Komen consolidating to focus on breast cancer research, direct patient support, advocacy
Susan G. Komen will double down on research and direct patient support and discard community grant making in a consolidation designed to strengthen the breast cancer organization’s hand headed into the post-coronavirus era......»»
Seattle Genetics" stock rises on early FDA nod for breast-cancer drug
Shares of Seattle Genetics Inc. gained 1.0% in trading on Friday after the Food and Drug Administration approved Tukysa for certain patients with HER2-positive breast cancer when given in combination with chemotherapy. The drug has a wholesale.....»»
Veracyte announces publication of study using Prosigna breast cancer test
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Shannen Doherty kept her stage 4 cancer diagnosis a secret while filming the 90210 reboot
Earl Gibson III/Getty Images 90210 actress Shannen Doherty revealed Tuesday she has stage four breast cancer on an emotional Good Morning America segment. .....»»
The Wall Street Journal: Google AI beats doctors at breast cancer detection some of the time
Google’s health research unit said it has developed an artificial-intelligence system that can match or outperform radiologists at detecting breast cancer, according to new research. But doctors still beat the machines in some cases......»»
Why These Breast Cancer Study Results Look So Promising
Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the 2019 San Antonio Breast Cancer........»»
NantHealth presents new breast cancer research findings at SABCS
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»